Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
ZLDPF
Stock Latest News
The Fly
Generate Biomedicines, Zealand Pharma enter protein therapeutics pact
23m ago
GENB
Premium
Company Announcements
Petrelintide Phase III Trial Puts Zealand Pharma in the Weight-Loss Spotlight
6d ago
ZLDPF
Premium
Company Announcements
Zealand Pharma Advances Petrelintide Into Phase III, Raising Its Profile in the Obesity Drug Race
6d ago
ZLDPF
Premium
Company Announcements
Petrelintide Phase III Trial Puts Zealand Pharma in the Obesity–Heart Disease Spotlight
6d ago
ZLDPF
Premium
The Fly
Zealand Pharma opens research hub in Cambridge, Massachusetts
12d ago
Premium
The Fly
Zealand announces initiation of registrational Phase 3 ZUPREME program
21d ago
CHRO
Premium
The Fly
Elvinix announces exclusive license agreement with Zealand Pharma
28d ago
Premium
The Fly
Zealand Pharma downgraded to Equal Weight from Overweight at Barclays
1M ago
Premium
The Fly
Zealand Pharma price target lowered to DKK 435 from DKK 460 at JPMorgan
2M ago
Premium
The Fly
Zealand Pharma enters $100M royalty purchase, sale pact with Royalty Pharma
2M ago
RPRX
Premium
The Fly
Zealand Pharma price target raised to DKK 420 from DKK 410 at Wells Fargo
2M ago
Premium
Pre-Earnings
ZLDPF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
Premium
Company Announcements
Zealand Pharma’s Dasiglucagon Study Moves Forward in Rare Childhood Disease
2M ago
ZLDPF
Premium
Company Announcements
Zealand Pharma’s New Psoriasis Trial Sets Early Stage for ZP9830
3M ago
ZLDPF
Premium
Company Announcements
Zealand Pharma Advances First-in-Human Obesity Drug Trial With ZP6590
3M ago
ZLDPF
Premium
The Fly
Zealand Pharma downgraded to Hold from Buy at Jefferies
3M ago
Premium
The Fly
Zealand Pharma downgraded to Hold from Buy at Berenberg
4M ago
Premium
Company Announcements
Roche and Zealand Advance Combo Obesity Drug Trial, Signaling New Momentum for ZLDPF
4M ago
ZLDPF
Premium
The Fly
Zealand Pharma announces Boehringer’s phase III results of survodutide
4M ago
Premium
The Fly
Zealand Pharma presents additional data from ZUPREME-1 trial
4M ago
Premium
The Fly
Zealand Pharma price target raised to DKK 300 from DKK 275 at Deutsche Bank
4M ago
Premium
The Fly
Zealand Pharma upgraded to Buy from Hold at SEB Equities
6M ago
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
